The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

AML3D (ASX:AL3) has signed a contract with the Australian Government Defence Science and Technology Group (DSTG) to supply components for testing in marine applications.

The A$0.24 million contract entails the 3D metal printing of two representative marine components using Nickel Aluminium Bronze (NAB) alloy and high-strength duplex steel alloy. Manufacturing of these test components will kick off immediately at AML3D’s facility in Adelaide (South Australia), and delivery is expected during the remainder of FY24.

“It is very exciting to be directly supplying test NAB and Duplex steel components to the DSTG, which is tasked with assessing the best of Australian science, technology and innovation to address Australia’s Defence and national security challenges,” AML3D CEO Sean Ebert said.

“AML3D’s WAM manufactured NAB and duplex steel has passed multiple rounds of marine defence testing in the US and here at home. This gives us confidence we will meet the DSTG requirements, creating opportunities for significant new contracts,” he added.

This contract marks a crucial milestone for AML3D as it continues to diversify into global defence markets, in addition to its strong growth trajectory in the United States.

In 2023, the company’s ‘Scale up’ strategy in the US secured contracts worth close to A$12 million, with a primary focus on supporting the US Navy’s submarine industrial base.

AML3D aims to expedite its entry into additional defence markets, including marine applications.

This contract underscores AML3D’s position as a trusted partner in delivering innovative solutions to defence agencies worldwide.

AL3 has been trading at 6 cents.

AL3 by the numbers
More From The Market Online

Keystone US Navy supply chain firm picks up AML3D’s 3D-print tech

Defence-focused metals-based 3D printing tech company AML3D has confirmed a US Navy supplier has leased its…

Canberra greenlights Maximus for Korean firm’s 30% farm-in at Lefroy

Maximus Resources has received approval from Canberra for a Korean mining firm to farm-in for 30%…

Telix Pharma gears up to launch US IPO

Telix Pharmaceuticals has announced it's working with Morgan Stanley to list depository shares on the NASDAQ.

Market Open: ASX200 set to rise as VIX hits 5-year-low

Good morning. It’s looking like a good start to the week on the futures market with…